Quadrant Capital Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,218
| Closed | -$215K | – | 1614 |
|
|
2025
Q1 | $215K | Buy |
7,218
+7,076
| +4,983% | +$211K | 0.01% | 1256 |
|
|
2024
Q4 | $4.07K | Hold |
142
| – | – | ﹤0.01% | 2354 |
|
|
2024
Q3 | $5.49K | Hold |
142
| – | – | ﹤0.01% | 2298 |
|
|
2024
Q2 | $4.57K | Hold |
142
| – | – | ﹤0.01% | 2313 |
|
|
2024
Q1 | $5.51K | Hold |
142
| – | – | ﹤0.01% | 2283 |
|
|
2023
Q4 | $4.37K | Sell |
142
-17
| -11% | -$523 | ﹤0.01% | 2310 |
|
|
2023
Q3 | $3.55K | Buy |
159
+17
| +12% | +$380 | ﹤0.01% | 2257 |
|
|
2023
Q2 | $3.05K | Sell |
142
-16
| -10% | -$344 | ﹤0.01% | 2319 |
|
|
2023
Q1 | $3.79K | Buy |
158
+16
| +11% | +$384 | ﹤0.01% | 2291 |
|
|
2022
Q4 | $3.29K | Buy |
142
+123
| +647% | +$2.85K | ﹤0.01% | 2302 |
|
|
2022
Q3 | $0 | Buy |
+19
| New | – | ﹤0.01% | 2656 |
|
|
2022
Q2 | – | Sell |
-22
| Closed | – | – | 2568 |
|
|
2022
Q1 | $0 | Buy |
+22
| New | – | ﹤0.01% | 2518 |
|